Neopharma is currently on a massive expansion drive and is currently evaluating several potential growth markets for its products. The company has entered into a joint venture with leading companies from across the globe. The company is in the final stages of negotiation in several countries such as US, Canada and Kenya among other countries. SBI Pharmaceuticals, a Neopharma subsidiary in Japan has a state-of-the-art facility that manufactures medicines, cosmetics, and health foods (dietary supplements) containing 5-ALA (5-Aminolevulinic Acid). Neopharma also has its own manufacturing facility in India and Brazil.